Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03369795
What this trial is testing

Add-on Methotrexate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Sheba Medical Center 100
Not applicableUnknownNCT00645580
What this trial is testing

Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

Who this might be right for
Schizophrenia
Sha'ar Menashe Mental Health Center 15
Not applicableStudy completedNCT00534222
What this trial is testing

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect

Who this might be right for
ManiaSchizophrenia
AstraZeneca 387
Not applicableStudy completedNCT02248987
What this trial is testing

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

Who this might be right for
Schizophrenia
Seoul National University Hospital 36
Not applicableLooking for participantsNCT02640911
What this trial is testing

An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 3,000
Post-approval studies (Phase 4)Study completedNCT00205699
What this trial is testing

Metabolic Effects of Antipsychotics in Children

Who this might be right for
AggressionAttention Deficit-HyperactivityOppositional Defiant Disorder+2 more
Washington University School of Medicine 144
Testing effectiveness (Phase 2)Study completedNCT00616798
What this trial is testing

RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Hoffmann-La Roche 323
Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Post-approval studies (Phase 4)Study completedNCT00000373
What this trial is testing

Treatment of Obsessive-Compulsive Disorder

Who this might be right for
Obsessive-Compulsive Disorder
University of Florida 74
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Testing effectiveness (Phase 2)WithdrawnNCT04761861
What this trial is testing

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
SchizophreniaDyslipidemias
Sadat City University
Testing effectiveness (Phase 2)Study completedNCT03319953
What this trial is testing

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Who this might be right for
Stable Schizophrenia
Neurocrine Biosciences 23
Post-approval studies (Phase 4)Study completedNCT01670019
What this trial is testing

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Who this might be right for
Major Depressive Disorder Without Psychotic Features
Duke University 46
Post-approval studies (Phase 4)Study completedNCT00835107
What this trial is testing

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

Who this might be right for
Depression, Bipolar
Queen's University 14
Large-scale testing (Phase 3)Study completedNCT01811459
What this trial is testing

Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium

Who this might be right for
Delirium
Centre hospitalier de l'Université de Montréal (CHUM) 107
Large-scale testing (Phase 3)Study completedNCT01192906
What this trial is testing

RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 624
Not applicableStudy completedNCT00894738
What this trial is testing

Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

Who this might be right for
Mental Disorders
Washington University School of Medicine 44
Testing effectiveness (Phase 2)Ended earlyNCT03351244
What this trial is testing

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

Who this might be right for
Schizophrenia
Boehringer Ingelheim 264
Testing effectiveness (Phase 2)Study completedNCT00357006
What this trial is testing

A Definitive Estrogen Patch Study (ADEPT)

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder(Not in Manic Phase)
The Alfred 180
Not applicableStudy completedNCT01534936
What this trial is testing

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

Who this might be right for
SchizophreniaAffective Symptoms
AstraZeneca 2,153
Next Page